3647 results for «520»
3647 results
Tricuspid and pulmonary valve intervention
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the challenges and innovations in tricuspid and pulmonary valve interventions. Discover cases involving imaging nightmares for treating severe tricuspid regurgitation, transcatheter pulmonary valve implantation for heavily calcified lesions, and the use of the "zipping technique" for massive tricuspid valve flail gaps. Explore the strategies...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
